TIMOTHY DANNEMILLER: Open Payments
NPI 1033143474 · GATESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 30 payments from 11 companies in 2025. Trend: 2023 $542 · 2024 $917 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $171 |
| Novo Nordisk Inc | 6 | $104 |
| ABBVIE INC. | 4 | $89 |
| PFIZER INC. | 4 | $75 |
| Lilly USA, LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $15 |
Products named: AIRSUPRA, QULIPTA, FARXIGA, Wegovy, NURTEC ODT, PREVNAR 20, BREZTRI, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
